Error: Could not add to watchlist. X

Credit Suisse Lux Biotechnology Equity Fund

+ Watchlist
CLABI1B:LX
517.41
USD
6.25
1.22%
As of 00:59:30 ET on 08/28/2015.
Fund Type
SICAV
52Wk Range
370.60 - 582.01
1 Yr Return
27.69%
YTD Return
15.60%
Previous Close
511.16
52Wk Range
370.60 - 582.01
1 Yr Return
27.69%
YTD Return
15.60%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 08/28/2015)
517.41
Total Assets (m USD) (on 08/28/2015)
248.637
Inception Date
10/05/2001
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
IRENE BEATRICE PUETTNER
Front Load Fee
0.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
0.90%
Expense Ratio
-
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 172.48 k 19.36 m 7.38
Biogen Inc 47.00 k 18.66 m 7.11
Amgen Inc 105.97 k 16.56 m 6.31
Celgene Corp 140.28 k 16.05 m 6.12
Incyte Corp 130.00 k 14.32 m 5.46
BioMarin Pharmaceutical Inc 109.44 k 13.74 m 5.24
Regeneron Pharmaceuticals Inc 25.00 k 12.81 m 4.89
Vertex Pharmaceuticals Inc 85.00 k 10.90 m 4.16
Medivation Inc 80.00 k 10.56 m 4.03
Alexion Pharmaceuticals Inc 52.75 k 8.64 m 3.30
Profile
Credit Suisse Lux Biotechnology Equity Fund is a SICAV incorporated in Luxembourg. The Fund is actively managed aiming to outperform the return of the NASDAQ Biotechnology TR benchmark. The Fund mainly invests in equity and equity-type securities of issuers engaged in the biotechnology industry.
ADDRESS
Credit Suisse AG
PHONE
-